Author Correction: Regulation of hnRNPA1 by microRNAs controls the miR-18a-K-RAS axis in chemotherapy-resistant ovarian cancer

Cell Discov. 2023 Nov 8;9(1):111. doi: 10.1038/s41421-023-00611-6.

Cristian Rodriguez-Aguayo^{1

2}, Paloma Del C Monroig¹, Roxana S Redis¹, Emine Bayraktar¹, Maria I Almeida^{1

3}, Cristina Ivan^{1

2}, Enrique Fuentes-Mattei¹, Mohammed H Rashed^{1

4}, Arturo Chavez-Reyes⁵, Bulent Ozpolat^{1

2}, Rahul Mitra^{2

6}, Anil K Sood^{2

6

7}, George A Calin^{1

2}, Gabriel Lopez-Berestein^{8

9

10}

¹ Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
² Center for RNA Interference and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
³ Instituto de Investigação e Inovação em Saúde/Institute for Research and Innovation in Health (I3S) and Instituto de Engenharia Biomédica (INEB), University of Porto, Porto, Portugal.
⁴ Department of Pharmacology and Toxicology, Faculty of Pharmacy, The University of Al-Azhar, Cairo, Egypt.
⁵ Center for Research and Advanced Studies, National Polytechnic Institute (CINVESTAV del IPN), Monterrey, Mexico.
⁶ Department of Gynecologic Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
⁷ Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
⁸ Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. glopez@mdanderson.org.
⁹ Center for RNA Interference and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. glopez@mdanderson.org.
¹⁰ Department of Gynecologic Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. glopez@mdanderson.org.

No abstract available

Publication types